Intravenous bisphosphonate therapy in children with spinal muscular atrophy

ConclusionThese findings suggest that in children with SMA, IV BP therapy appears to be safe with minimal acute side effects and effective to reduce fracture rate. Caution is still needed given the occurrence of an atypical femur fracture in SMA population.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research